Medpharma Partners

Takeda Pharmaceuticals USA, based in Cambridge, is a leading global pharmaceutical company dedicated to research and development. Their mission is to improve the health and well-being of patients worldwide by transforming scientific discoveries into innovative medicines that make a positive impact on people's lives. Generated from their website's infomation

Adecto Pharmaceuticals, Inc. is a preclinical-stage biotechnology company based in Brookline, MA, focused on developing targeted therapies for aggressive ADAM8-positive cancers, along with a companion diagnostic to identify suitable patients. With over 30 years of research, Adecto aims to enhance patient outcomes by addressing the critical drivers of tumor growth and metastasis linked to the ADAM8 protein. Currently, there are no approved therapies or diagnostics for patients with ADAM8-positive tumors, which include various aggressive cancers such as those of the breast, stomach, colon, lungs, liver, and pancreas. Adecto's initial focus is on breast cancer, with plans to expand its therapeutic offerings to other oncology indications in the future. Generated from the website

Merck Research Laboratories, based in Boston, MA, has been at the forefront of biopharmaceutical innovation for over 130 years, focusing on the development of significant medicines and vaccines aimed at improving global health. Their research encompasses various areas, including oncology, infectious diseases, and immunology, while actively pursuing innovative scientific advancements through collaborations and clinical trials. The company is dedicated to operating sustainably and responsibly, ensuring a safe and healthy future for communities worldwide. Through initiatives like the Merck for Mothers program and the Patient Assistance Program, Merck demonstrates its commitment to making healthcare accessible and impactful for all individuals. Generated from the website